Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

3.4

Margin Of Safety %

Put/Call OI Ratio

0.23

EPS Next Q Diff

0.13

EPS Last/This Y

0.78

EPS This/Next Y

0.15

Price

7.16

Target Price

10.67

Analyst Recom

1.93

Performance Q

-24.26

Relative Volume

1.01

Beta

1.63

Ticker: NEO




19 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-06-02NEO7.160.280.0617588
2025-06-03NEO7.460.282.2217684
2025-06-04NEO7.380.300.0018216
2025-06-05NEO7.120.304.0118404
2025-06-06NEO7.410.350.0019273
2025-06-09NEO7.550.350.0319282
2025-06-10NEO7.860.350.1019255
2025-06-11NEO7.840.350.2819268
2025-06-12NEO7.380.350.0519578
2025-06-13NEO7.070.350.1119651
2025-06-16NEO7.410.350.0019720
2025-06-17NEO6.990.350.0119764
2025-06-18NEO6.950.290.0019235
2025-06-20NEO70.300.0519099
2025-06-23NEO7.010.310.0115883
2025-06-24NEO7.220.300.3916255
2025-06-25NEO7.180.300.0616541
2025-06-26NEO7.150.260.0118514
2025-06-27NEO7.170.230.0020359
DateSymbolLastP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-06-02NEO7.16-7.1- 0.15
2025-06-03NEO7.48-7.1- 0.15
2025-06-04NEO7.39-7.1- 0.15
2025-06-05NEO7.13-7.1- 0.15
2025-06-06NEO7.42-7.7- 0.15
2025-06-09NEO7.56-7.7- 0.15
2025-06-10NEO7.86-7.7- 0.15
2025-06-11NEO7.84-7.7- 0.15
2025-06-12NEO7.39-7.7- 0.15
2025-06-13NEO7.06-7.7- 0.15
2025-06-16NEO7.41-7.7- 0.15
2025-06-17NEO6.99-7.7- 0.15
2025-06-18NEO6.95-7.7- 0.15
2025-06-20NEO7.00-7.7- 0.15
2025-06-23NEO7.01-7.7- 0.15
2025-06-24NEO7.23-7.7- 0.15
2025-06-25NEO7.18-7.7- 0.15
2025-06-26NEO7.16-7.7- 0.15
2025-06-27NEO7.16-7.7- 0.15
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-06-02NEO4.702.394.94
2025-06-03NEO4.702.394.94
2025-06-04NEO4.702.394.94
2025-06-05NEO4.702.394.94
2025-06-06NEO4.702.394.94
2025-06-09NEO4.702.484.95
2025-06-10NEO4.422.484.95
2025-06-11NEO4.422.484.32
2025-06-12NEO4.422.484.32
2025-06-13NEO4.422.484.32
2025-06-16NEO4.422.644.32
2025-06-17NEO4.422.644.32
2025-06-18NEO4.422.644.32
2025-06-19NEO4.422.644.32
2025-06-20NEO4.422.644.32
2025-06-24NEO4.422.644.32
2025-06-25NEO4.422.644.32
2025-06-26NEO4.422.643.40
2025-06-27NEO4.422.643.40
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

-0.08

Avg. EPS Est. Current Quarter

0.03

Avg. EPS Est. Next Quarter

0.05

Insider Transactions

4.42

Institutional Transactions

2.64

Beta

1.63

Average Sales Estimate Current Quarter

183

Average Sales Estimate Next Quarter

192

Fair Value

Quality Score

45

Growth Score

46

Sentiment Score

80

Actual DrawDown %

88.4

Max Drawdown 5-Year %

-89.3

Target Price

10.67

P/E

Forward P/E

23.96

PEG

P/S

1.37

P/B

1.04

P/Free Cash Flow

EPS

-0.61

Average EPS Est. Cur. Y​

0.15

EPS Next Y. (Est.)

0.31

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-11.54

Relative Volume

1.01

Return on Equity vs Sector %

-32.6

Return on Equity vs Industry %

-19.3

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

NeoGenomics, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 2200
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through two segments: Clinical Services and Advanced Diagnostics. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
stock quote shares NEO – Neogenomics Inc. Stock Price stock today
news today NEO – Neogenomics Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch NEO – Neogenomics Inc. yahoo finance google finance
stock history NEO – Neogenomics Inc. invest stock market
stock prices NEO premarket after hours
ticker NEO fair value insiders trading